TOWA PHARMACEUTICAL CO.,LTD
TOWA PHARMACEUTICAL CO., LTD., headquartered in Japan, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic drugs and active pharmaceutical ingredients. Founded in 1950, the company has established a strong presence in both domestic and international markets, with significant operations across Asia and beyond. Renowned for its commitment to innovation and quality, TOWA offers a diverse portfolio of products that cater to various therapeutic areas, including oncology and cardiovascular health. The company’s unique approach to research and development has positioned it as a leader in the generic pharmaceuticals sector, achieving notable milestones in regulatory approvals and market expansion. With a focus on enhancing patient care, TOWA PHARMACEUTICAL continues to make significant contributions to the global healthcare landscape.
DitchCarbon Score
How does TOWA PHARMACEUTICAL CO.,LTD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TOWA PHARMACEUTICAL CO.,LTD's score of 23 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
TOWA PHARMACEUTICAL CO.,LTD's reported carbon emissions
In 2022, TOWA PHARMACEUTICAL CO., LTD reported total carbon emissions of approximately 1,045,925,000 kg CO2e, with significant contributions from Scope 3 emissions, which accounted for about 1,045,925,000 kg CO2e. Scope 1 emissions were approximately 29,948,000 kg CO2e, while Scope 2 emissions totalled around 47,661,000 kg CO2e. Comparatively, in 2021, the company recorded total emissions of about 947,466,000 kg CO2e, with Scope 3 emissions at approximately 947,466,000 kg CO2e, Scope 1 emissions at around 30,098,000 kg CO2e, and Scope 2 emissions at about 43,180,000 kg CO2e. Despite these figures, TOWA PHARMACEUTICAL CO., LTD has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or any formal climate pledges. The absence of defined reduction strategies highlights a potential area for improvement in their climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 30,098,000 | 00,000,000 |
| Scope 2 | 43,180,000 | 00,000,000 |
| Scope 3 | 947,466,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TOWA PHARMACEUTICAL CO.,LTD is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
